Crossmark

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia

Crossref DOI link: https://doi.org/10.1038/leu.2016.225

Published Online: 2016-09-02

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Burnett, A K

Russell, N H

Hills, R K

Kell, J

Nielsen, O J

Dennis, M

Cahalin, P

Pocock, C

Ali, S

Burns, S

Freeman, S

Milligan, D

Clark, R E
License Information

Text and Data Mining valid from 2016-09-02
More Information

Article History

Received: 21 April 2016

Revised: 14 June 2016

Accepted: 12 July 2016

First Online: 2 September 2016

Competing interests

: The authors declare no conflict of interest.